SELUTION4SFA Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 300 participants.

Also called NCT05132361

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05132361
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Germany, Hong Kong SAR China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05132361. Randomized; single masking; primary purpose treatment. Start 2022-12-01 (actual); primary completion 2026-07-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SELUTION4SFA Trial
Condition
Peripheral Arterial Disease
Condition
Superficial Femoral Artery Stenosis
Intervention (Device)
SELUTION SLR™ 018 DEB
Intervention (Device)
Plain (Uncoated) Balloon Angioplasty (PTA)
Lead sponsor
M.A. Med Alliance S.A. (class: industry)
Collaborator
NAMSA (class: other)
Collaborator
Cordis US Corp. (class: industry)

Record details

Record id
cardio:ct-nct05132361
Content hash
a2125487d77a4224cb9a2d564c142a827c9dbfb0a3df0e0a636397d1a71be40b